Brief: Neovacs: In Vivo Proof Of Concept Success For Il-4/Il-13 Kinoid

Neovacs SA

07/11/2018 16:57

Nov 7 (Reuters) - NEOVACS SA  ALNEV.PA :
    * REG-NEOVACS ANNOUNCES IN VIVO PROOF OF CONCEPT SUCCESS FOR
ITS
IL-4 / IL-13 KINOID A NEW THERAPEUTIC VACCINE  TO TREAT
MITE-INDUCED ASTHMA
    * IL-4 / IL-13 KINOID INDUCES STRONG PRODUCTION OF
NEUTRALIZING
ANTIBODIES AGAINST CYTOKINES IL-4 AND IL-13 AND INHIBITS
BRONCHOCONSTRICTION
    * RESULTS OBTAINED IN THIS PRECLINICAL STUDY SHOW THAT
VACCINE IS
ABLE TO INHIBIT BRONCHOCONSTRICTION

Source text for Eikon:  ID:nGNE39qfWt 
Further company coverage:  ALNEV.PA 

 (Gdynia Newsroom)
 ((gdynia.newsroom@thomsonreuters.com; +48 58 772 09 20;))